Director sold ~$701K of Jazz Pharmaceuticals
Scheduled in advanceLoading…
Traded Mar 9, 2026 · Filed Mar 10, 2026
Jazz Pharmaceuticals's SVP, Chief Accounting Officer sold $235K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$235,444
Shares × reported transaction price
13 days after results of Feb 24, 2026, 57 days before results of May 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.5% | −0.9% | −1.5% |
| 30 days | +6.6% | +0.4% | +6.2% |
| 90 days | +24.8% | +9.2% | +15.6% |
| 180 days | +29.1% | +13.1% | +16.0% |
Past results only. Not a forecast.
Director sold ~$701K of Jazz Pharmaceuticals
Scheduled in advanceDirector sold ~$438K of Jazz Pharmaceuticals
Scheduled in advanceDirector sold ~$4.6K of Jazz Pharmaceuticals
Scheduled in advance